4//SEC Filing
Lumira Capital Investment Management Inc. 4
Accession 0000905148-24-000773
CIK 0001980845other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:20 PM ET
Size
12.5 KB
Accession
0000905148-24-000773
Insider Transaction Report
Form 4
Transactions
- Award
Common Shares
2024-02-20$10.00/sh+644,965$6,449,650→ 993,651 total(indirect: By IRA) - Award
Common Shares
2024-02-20$10.00/sh+155,035$1,550,350→ 238,851 total(indirect: By IRA)
Holdings
- 1,341,790(indirect: By IRA)
Common Shares
- 152,974(indirect: By IRA)
Common Shares
- 44,647(indirect: By IRA)
Common Shares
- 1,077,386(indirect: By IRA)
Common Shares
Footnotes (5)
- [F1]This Form 4 is filed jointly by Lumira Ventures III, L.P. ("Lumira III"), Lumira Ventures III (International), L.P. ("Lumira III Int'l"), Lumira Ventures IV, L.P. ("Lumira IV"), Lumira Ventures IV (International), L.P. ("Lumira IV Int'l"), Merck Lumira Biosciences Fund, L.P. ("Merck-Lumira"), Merck Lumira Biosciences Fund (Quebec), L.P. ("Merck-Lumira B" and, together with Lumira III, Lumira III Int'l, Lumira IV, Lumira IV Int'l, and Merck-Lumira, the "Lumira Entities"), Lumira Capital Investment Management Inc. ("Lumira Mgmt"), Lumira Ventures III GP, L.P., Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira Capital GP, L.P., Lumira GP Inc. and Lumira GP Holdings Co. (collectively, the "Reporting Person").
- [F2]Lumira IV and Lumira IV Int'l are controlled by their general partner, Lumira IV GP 2020 Inc., and managed by Lumira Mgmt.
- [F3]Lumira III and Lumira III Int'l are controlled by their general partner, Lumira Ventures III GP, L.P., and managed by Lumira Mgmt. Lumira Ventures III GP, L.P. is controlled by its general partners, Lumira III GP Inc. and Lumira III GP Holdings Co.
- [F4]Merck-Lumira and Merck-Lumira B are controlled by their general partner, Lumira Capital GP, L.P., and managed by Lumira Mgmt. Lumira Capital GP, L.P. is controlled by its general partners, Lumira GP Inc. and Lumira GP Holdings Co.
- [F5]Gerald Brunk, a director of the Issuer, is an executive officer of each of Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira GP Inc., Lumira GP Holdings Co. and Lumira Mgmt and reports his beneficial ownership of these securities on a separate Form 4. Each of Lumira Ventures III GP, L.P., Lumira III GP Inc., Lumira III GP Holdings Co., Lumira IV GP 2020 Inc., Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Mgmt and Mr. Brunk may be deemed to beneficially own the securities held by the respective Lumira Entities, but each disclaims beneficial ownership except to the extent of their respective pecuniary interests therein, if any.
Documents
Issuer
enGene Holdings Inc.
CIK 0001980845
Entity typeother
IncorporatedCanada (Federal Level)
Related Parties
1- filerCIK 0001702636
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:20 PM ET
- Size
- 12.5 KB